These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurotoxicity after chemotherapy with vinorelbine. Lonardi F; Pavanato G; Ferrari V; Bonciarelli G; Jirillo A; Balli M Eur J Cancer; 1993; 29A(12):1794. PubMed ID: 8398315 [No Abstract] [Full Text] [Related]
4. Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study. Buccheri G; Ferrigno D Cancer; 2000 Jun; 88(12):2677-85. PubMed ID: 10870049 [TBL] [Abstract][Full Text] [Related]
5. Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study. Karampeazis A; Vamvakas L; Agelidou A; Kentepozidis N; Chainis K; Chandrinos V; Vardakis N; Pallis AG; Christophyllakis C; Georgoulias V Clin Lung Cancer; 2011 May; 12(3):155-60. PubMed ID: 21663857 [TBL] [Abstract][Full Text] [Related]
6. Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma. Miller VA; Ng KK; Krug LM; Perez W; Pizzo B; Heelan RT; Kris MG Cancer; 2000 Mar; 88(5):1045-50. PubMed ID: 10699893 [TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
8. [A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)]. Locher C; Pourel N; Marin B; Vergnenègre A; Rev Mal Respir; 2011 Jan; 28(1):58-65. PubMed ID: 21277475 [TBL] [Abstract][Full Text] [Related]
9. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy. Goa KL; Faulds D Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948 [TBL] [Abstract][Full Text] [Related]
11. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer. Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824 [TBL] [Abstract][Full Text] [Related]
12. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study. Igishi T; Shigeoka Y; Yasuda K; Suyama H; Katayama S; Sugitani A; Matsumoto S; Yamamoto M; Ueda Y; Takeda K; Sumikawa T; Sako T; Kodani M; Hitsuda Y; Shimizu E J Thorac Oncol; 2009 Mar; 4(3):376-82. PubMed ID: 19190514 [TBL] [Abstract][Full Text] [Related]
13. Vinorelbine approved for advanced non-small-cell lung cancer. Am J Health Syst Pharm; 1995 Apr; 52(7):678. PubMed ID: 7627734 [No Abstract] [Full Text] [Related]
14. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly. Chen YM; Perng RP; Shih JF; Whang-Peng J Lung Cancer; 2008 Aug; 61(2):214-9. PubMed ID: 18243407 [TBL] [Abstract][Full Text] [Related]
15. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
16. [Paralytic ileus due to vinorelbine]. Esquerdo Galiana G; Briceño García H; Llorca Ferrándiz C; Cervera Grau JM Clin Transl Oncol; 2005 May; 7(4):169-70. PubMed ID: 15960925 [TBL] [Abstract][Full Text] [Related]
18. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients. Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715 [TBL] [Abstract][Full Text] [Related]
19. Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine. Liebmann J; Friedman K Am J Med; 1996 Dec; 101(6):658-9. PubMed ID: 9003116 [No Abstract] [Full Text] [Related]
20. Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer. Kurishima K; Kagohashi K; Ishikawa H; Satoh H Clin Lung Cancer; 2012 Sep; 13(5):396; author reply 397. PubMed ID: 22484151 [No Abstract] [Full Text] [Related] [Next] [New Search]